Image_12_The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis.TIF (56.28 kB)

Image_12_The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis.TIF

Download (56.28 kB)
figure
posted on 30.04.2019, 04:41 by Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong

Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains controversial.

Methods: We performed a systematic review and meta-analysis to evaluate the association of various CD44 isoforms and overall survival (OS) and clinicopathological features of CRC patients.

Results: A total of 48 studies were included in the meta-analysis. Total CD44 isoforms overexpression was significantly correlated with worse OS of patients with CRC (HR = 1.32, 95% CI = 1.08–1.61, P = 0.007). In a stratified analysis, a higher level of either CD44v6 or CD44v2 had an unfavorable impact on OS (HRCD44v6 = 1.50, 95% CI = 1.10–2.14, P = 0.010; HRCD44v2 = 2.93, 95% CI = 1.49–5.77, P = 0.002). Additionally, CD44 was shown to be associated with some clinicopathological features, such as lymph node metastasis (ORCD44 = 1.56, 95% CI = 1.01–2.41, P = 0.044; ORCD44v6 = 1.97, 95% CI = 1.19–3.26, P = 0.008; ORTotal CD44 isoforms = 1.57, 95% CI = 1.15–2.14, P = 0.004), distant metastasis (ORCD44 = 2.90, 95% CI = 1.08–7.83, P = 0.035; ORTotal CD44 isoforms = 1.89, 95% CI = 1.02–3.53, P = 0.044). Moreover, a high level of CD44 showed a possible correlation with poor differentiation (ORTotal CD44 isoforms = 1.44, 95% CI = 1.00–2.08, P = 0.051), elevated level of CD44v6 tend to be correlated with tumor size (OR = 1.71, 95% CI = 0.99–2.96, P = 0.056).

Conclusions: This meta-analysis demonstrated that CD44 overexpression might be an unfavorable prognostic factor for CRC patients and could be used to predict poor differentiation, lymph node metastasis and distant metastasis.

History

References

Licence

Exports